Home › Companies › AKEBIA THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and AKEBIA THERAPEUTICS INC.’s Form 8-K, filed 2025-06-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore AKEBIA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AKEBIA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: John P. Butler | 130,424,556 | -- | -- | 20,706,403 | 38,964,524 | Majority: yes |
| Elect Director: Myles Wolf, M.D., M.M.Sc. | 119,938,011 | -- | -- | 31,192,948 | 38,964,524 | Majority: yes |
| Proposal 2: The proposal to approve an amendment to the Company's 2023 Stock Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 18,900,000 shares and to make certain other changes to the plan was approved as fo | 102,750,481 | 48,208,800 | 171,678 | -- | 38,964,524 | Majority: yes |
| Proposal 3: The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers was approved as follows: | 110,676,718 | 39,006,990 | 1,447,251 | -- | 38,964,524 | Majority: yes |
| Proposal 4: The proposal to ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was approved as follows: | 178,590,132 | 8,896,080 | 2,609,271 | -- | -- | Majority: yes |
Source: AKEBIA THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-13 — read the filing on EDGAR.
Each item below shows how the 133 asset managers that disclosed a AKEBIA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
AKEBIA THERAPEUTICS INC.’s own tally for this item (“Proposal 3: The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers was approved as follows:”): 110,676,718 for, 39,006,990 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 262,635,836 outstanding shares: 42% for, 15% against (57% of the company cast a for/against vote).
The 132 asset managers below cast 99.0% of the shares they voted on this item FOR (78,356,004 for, 728,219 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,720,828 | 0 | 0 | 0 | For |
| BlackRock | 10,873,623 | 47,145 | 0 | 0 | For |
| State Street | 8,680,556 | 18,317 | 0 | 0 | For |
| Fidelity | 6,232,525 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,058,729 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 4,973,840 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 2,665,158 | 0 | 0 | 0 | For |
| Woodline Partners LP | 2,485,578 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 2,000,000 | 0 | 0 | 0 | For |
| Renaissance | 1,714,777 | 0 | 0 | 0 | For |
| Federated Hermes | 1,682,075 | 0 | 0 | 0 | For |
| Northern Trust | 1,510,002 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,492,799 | 0 | 0 | 0 | For |
| SEI | 1,473,161 | 0 | 0 | 0 | For |
| Citadel | 1,377,666 | 0 | 0 | 0 | For |
| Charles Schwab | 1,245,828 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 1,111,837 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 974,430 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 895,000 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 716,335 | 0 | 0 | 0 | For |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 689,593 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 666,684 | 0 | 0 | 0 | For |
| Equitable | 500,416 | 0 | 0 | 0 | For |
| Wellington | 484,866 | 0 | 0 | 0 | For |
| Informed Momentum Co LLC | 463,556 | 0 | 0 | 0 | For |
Showing the 25 largest of 132 asset managers. See all 132 in the interactive database.
Combines 5 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
AKEBIA THERAPEUTICS INC.’s own tally for this item (“Proposal 2: The proposal to approve an amendment to the Company's 2023 Stock Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 18,900,000 shares and to make certain othe”): 102,750,481 for, 48,208,800 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 262,635,836 outstanding shares: 39% for, 18% against (57% of the company cast a for/against vote).
The 46 asset managers below cast 99% of the shares they voted on this item FOR (33,473,759 for, 399,051 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,503,928 | 0 | 0 | 0 | For |
| BlackRock | 7,141,971 | 0 | 0 | 0 | For |
| Fidelity | 5,360,993 | 0 | 0 | 0 | For |
| State Street | 2,389,197 | 116 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 895,000 | 0 | 0 | 0 | For |
| Federated Hermes | 820,556 | 0 | 0 | 0 | For |
| Charles Schwab | 622,914 | 0 | 0 | 0 | For |
| Equitable | 500,416 | 0 | 0 | 0 | For |
| SEI | 478,096 | 0 | 0 | 0 | For |
| TIAA | 0 | 378,555 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 358,955 | 0 | 0 | 0 | For |
| Lincoln Financial | 291,407 | 0 | 0 | 0 | For |
| Goldman Sachs | 269,320 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 195,921 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 172,910 | 0 | 0 | 0 | For |
| Global X | 125,897 | 0 | 0 | 0 | For |
| Nationwide | 111,707 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 108,111 | 0 | 0 | 0 | For |
| Pacific Life | 103,851 | 0 | 0 | 0 | For |
| Northern Trust | 101,831 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 94,810 | 0 | 0 | 0 | For |
| Invesco | 92,630 | 0 | 0 | 0 | For |
| Dimensional | 83,919 | 0 | 0 | 0 | For |
| ProShares | 79,701 | 0 | 0 | 0 | For |
| Brighthouse | 78,248 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Combines 4 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
AKEBIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: John P. Butler”): 130,424,556 for, 20,706,403 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 262,635,836 outstanding shares: 49.7% for, 8% withheld (58% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (33,758,405 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,503,928 | 0 | 0 | 0 | For |
| BlackRock | 7,141,971 | 0 | 0 | 0 | For |
| Fidelity | 5,360,993 | 0 | 0 | 0 | For |
| State Street | 2,389,313 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 895,000 | 0 | 0 | 0 | For |
| Federated Hermes | 820,556 | 0 | 0 | 0 | For |
| Charles Schwab | 622,914 | 0 | 0 | 0 | For |
| Equitable | 500,416 | 0 | 0 | 0 | For |
| SEI | 478,096 | 0 | 0 | 0 | For |
| TIAA | 378,555 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 358,955 | 0 | 0 | 0 | For |
| Lincoln Financial | 291,407 | 0 | 0 | 0 | For |
| Goldman Sachs | 269,320 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 195,921 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 172,910 | 0 | 0 | 0 | For |
| Global X | 125,897 | 0 | 0 | 0 | For |
| Nationwide | 111,707 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 108,111 | 0 | 0 | 0 | For |
| Pacific Life | 103,851 | 0 | 0 | 0 | For |
| Northern Trust | 101,831 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 94,810 | 0 | 0 | 0 | For |
| Invesco | 92,630 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 83,919 | 0 | Abstain |
| ProShares | 79,701 | 0 | 0 | 0 | For |
| Brighthouse | 78,248 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
AKEBIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Myles Wolf, M.D., M.M.Sc.”): 119,938,011 for, 31,192,948 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 262,635,836 outstanding shares: 45.7% for, 12% withheld (58% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (29,503,975 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,503,928 | 0 | 0 | 0 | For |
| BlackRock | 7,141,971 | 0 | 0 | 0 | For |
| Fidelity | 5,360,993 | 0 | 0 | 0 | For |
| State Street | 5,600 | 0 | 2,383,713 | 0 | Abstain |
| FRANKLIN STRATEGIC SERIES | 895,000 | 0 | 0 | 0 | For |
| Federated Hermes | 820,556 | 0 | 0 | 0 | For |
| Charles Schwab | 622,914 | 0 | 0 | 0 | For |
| Equitable | 386,066 | 0 | 114,350 | 0 | For |
| SEI | 478,096 | 0 | 0 | 0 | For |
| TIAA | 378,555 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 358,955 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 291,407 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 269,320 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 195,921 | 0 | Abstain |
| SEI Exchange Traded Funds | 172,910 | 0 | 0 | 0 | For |
| Global X | 125,897 | 0 | 0 | 0 | For |
| Nationwide | 12,110 | 0 | 99,597 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 108,111 | 0 | Abstain |
| Pacific Life | 103,851 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 101,831 | 0 | Abstain |
| Bridge Builder Trust | 94,810 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 92,630 | 0 | Abstain |
| Dimensional | 0 | 0 | 83,919 | 0 | Abstain |
| ProShares | 0 | 0 | 79,701 | 0 | Abstain |
| Brighthouse | 0 | 0 | 78,248 | 0 | Abstain |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
AKEBIA THERAPEUTICS INC.’s own tally for this item (“Proposal 4: The proposal to ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was approved as follows:”): 178,590,132 for, 8,896,080 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 262,635,836 outstanding shares: 68% for, 3% against (71% of the company cast a for/against vote).
The 45 asset managers below cast 99.9% of the shares they voted on this item FOR (33,868,893 for, 3,374 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,503,928 | 0 | 0 | 0 | For |
| BlackRock | 7,141,971 | 0 | 0 | 0 | For |
| Fidelity | 5,360,993 | 0 | 0 | 0 | For |
| State Street | 2,389,197 | 116 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 895,000 | 0 | 0 | 0 | For |
| Federated Hermes | 820,556 | 0 | 0 | 0 | For |
| Charles Schwab | 622,914 | 0 | 0 | 0 | For |
| Equitable | 500,416 | 0 | 0 | 0 | For |
| SEI | 478,096 | 0 | 0 | 0 | For |
| TIAA | 378,555 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 358,955 | 0 | 0 | 0 | For |
| Lincoln Financial | 291,407 | 0 | 0 | 0 | For |
| Goldman Sachs | 269,320 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 195,921 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 172,910 | 0 | 0 | 0 | For |
| Global X | 125,897 | 0 | 0 | 0 | For |
| Nationwide | 111,707 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 108,111 | 0 | 0 | 0 | For |
| Pacific Life | 103,851 | 0 | 0 | 0 | For |
| Northern Trust | 101,831 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 94,810 | 0 | 0 | 0 | For |
| Invesco | 92,630 | 0 | 0 | 0 | For |
| Dimensional | 83,919 | 0 | 0 | 0 | For |
| ProShares | 79,701 | 0 | 0 | 0 | For |
| Brighthouse | 78,248 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Ranked by the number of AKEBIA THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 262,635,836 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.84% |
| 2 | BlackRock | 4.16% |
| 3 | State Street | 3.31% |
| 4 | Fidelity | 2.37% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.93% |
| 6 | GREAT POINT PARTNERS LLC | 1.89% |
| 7 | FRANKLIN ADVISERS INC | 1.01% |
| 8 | Woodline Partners LP | 0.95% |
| 9 | Nantahala Capital Management, LLC | 0.76% |
| 10 | Renaissance | 0.65% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 5.84% | 13F |
| Vanguard Group | 4.83% | 13F |
| State Street | 2.59% | 13F |
| Satter Muneer A | 2.19% | 13G |
| John P. Butler | 1.93% | DEF14A |
| Geode Capital | 1.92% | 13F |
| Renaissance Technologies | 1.53% | 13F |
| Citadel Advisors | 1.46% | 13F |
| Goldman Sachs | 1.04% | 13F |
| Morgan Stanley | 1.02% | 13F |
Percentages above are of 262,635,836 shares outstanding, as reported by AKEBIA THERAPEUTICS INC. on its Form 10-Q dated 2025-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AKEBIA THERAPEUTICS INC.’s 10-Q dated 2025-05-05. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AKEBIA THERAPEUTICS INC.'s shareholder meeting held 2025-06-10, in the 2024-2025 proxy season, 133 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 746 separate fund positions. On the most widely held item on that ballot — Hold an advisory vote on the compensation of Akebia's named executive officers; — FOR was 74% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AKEBIA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-13.
AKEBIA THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.